Jim Simons’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $571K | Buy |
63,912
+17,080
| +36% | +$170K | ﹤0.01% | 2550 |
|
|
2025
Q4 | $390K | Sell |
46,832
-9,389
| -17% | -$94.7K | ﹤0.01% | 2671 |
|
|
2025
Q3 | $675K | Buy |
56,221
+2,046
| +4% | +$25K | ﹤0.01% | 2676 |
|
|
2025
Q2 | $459K | Buy |
54,175
+8,875
| +20% | +$90.5K | ﹤0.01% | 2877 |
|
|
2025
Q1 | $512K | Buy |
45,300
+1,065
| +2% | +$19.3K | ﹤0.01% | 2736 |
|
|
2024
Q4 | $902K | Buy |
44,235
+32,768
| +286% | +$956K | ﹤0.01% | 2552 |
|
|
2024
Q3 | $455K | Buy |
11,467
+1,197
| +12% | +$32.2K | ﹤0.01% | 2832 |
|
|
2024
Q2 | $181K | Buy |
10,270
+9,219
| +877% | +$156K | ﹤0.01% | 3064 |
|
|
2024
Q1 | $17K | Sell |
1,051
-8,769
| -89% | -$127K | ﹤0.01% | 3602 |
|
|
2023
Q4 | $186K | Buy |
9,820
+8,416
| +599% | +$158K | ﹤0.01% | 3156 |
|
|
2023
Q3 | $29K | Sell |
1,404
-33,508
| -96% | -$1.02M | ﹤0.01% | 3475 |
|
|
2023
Q2 | $1.91M | Buy |
34,912
+27,040
| +343% | +$831K | ﹤0.01% | 2030 |
|
|
2023
Q1 | $142K | Buy |
7,872
+4,179
| +113% | +$72K | ﹤0.01% | 3387 |
|
|
2022
Q4 | $37K | Sell |
3,693
-29
| -0.8% | -$310 | ﹤0.01% | 3855 |
|
|
2022
Q3 | $49K | Buy |
3,722
+220
| +6% | +$3.33K | ﹤0.01% | 3764 |
|
|
2022
Q2 | $45K | Buy |
3,502
+945
| +37% | +$25K | ﹤0.01% | 4013 |
|
|
2022
Q1 | $133K | Buy |
2,557
+507
| +25% | +$21.5K | ﹤0.01% | 3747 |
|
|
2021
Q4 | $92K | Buy |
2,050
+918
| +81% | +$49.2K | ﹤0.01% | 3695 |
|
|
2021
Q3 | $74K | Sell |
1,132
-2,445
| -68% | -$185K | ﹤0.01% | 3355 |
|
|
2021
Q2 | $358K | Sell |
3,577
-8,823
| -71% | -$910K | ﹤0.01% | 3085 |
|
|
2021
Q1 | $1.58M | Buy |
12,400
+3,576
| +41% | +$529K | ﹤0.01% | 2374 |
|
|
2020
Q4 | $980K | Buy |
8,824
+6,308
| +251% | +$706K | ﹤0.01% | 2512 |
|
|
2020
Q3 | $296K | Buy |
2,516
+2,019
| +406% | +$349K | ﹤0.01% | 3002 |
|
|
2020
Q2 | $107K | Sell |
497
-159
| -24% | -$37.6K | ﹤0.01% | 3266 |
|
|
2020
Q1 | $148K | Buy |
656
+281
| +75% | +$80.1K | ﹤0.01% | 3163 |
|
|
2019
Q4 | $101K | Buy |
+375
| New | +$94.3K | ﹤0.01% | 3321 |
|
|
2019
Q2 | – | Sell |
-264
| Closed | -$165K | – | 3724 |
|
|
2019
Q1 | $165K | Buy |
+264
| New | +$120K | ﹤0.01% | 3237 |
|
|
2013
Q3 | – | Sell |
-1,688
| Closed | -$670K | – | 2931 |
|
|
2013
Q2 | $670K | Buy |
+1,688
| New | +$716K | ﹤0.01% | 2111 |
|
Other funds holding RMTI
VCM
VFT
WANY
Jim Simons's RMTI Position: Q1 2026 in Review
Jim Simons increased its Rockwell Medical (RMTI) stake by 36% in Q1 2026, buying an estimated $170K and bringing the position to 63,912 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #2550.
Jim Simons first reported a position in RMTI in Q2 2013 and has held it in 28 quarters since. The position peaked at $1.91M in Q2 2023. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.
- Jim Simons held 63,912 shares of Rockwell Medical worth $571K as of Q1 2026.
- Jim Simons bought 17,080 Rockwell Medical shares in Q1 2026, an estimated $170K.
- Rockwell Medical made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2550 holding.
- Jim Simons first reported a position in Rockwell Medical in Q2 2013 and has held it in 28 quarters since.
- Jim Simons's Rockwell Medical position peaked at $1.91M in Q2 2023.
- 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.